Actively Recruiting
Vascular Function in Health and Disease: Rehabilitation for Hypertension and Exercise Effects on Skeletal Muscle
Led by Russell Richardson · Updated on 2025-09-26
420
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying how blood flow to muscles is controlled and how this changes with age and certain diseases such as chronic obstructive pulmonary disease (COPD), sepsis, pulmonary hypertension, and cardiovascular disease. The study focuses on four key pathways that affect blood vessel constriction and dilation: Angiotensin-II, Endothelin-1, Nitric Oxide, and oxidative stress. The goal is to better understand how these pathways contribute to reduced blood flow during exercise and whether these changes can be improved. Participants will receive various treatments including exercise tests and drugs that affect blood vessel function, such as Nitric Oxide blockers, antioxidants, receptor antagonists, and other vasoactive agents. These treatments will be given through catheter placements for measurements and infusions. Different groups include healthy young adults, older adults, and patients with conditions like COPD, pulmonary arterial hypertension, heart failure, and hypertension. The study will also evaluate effects before and after exercise training. During the study, participants will undergo tests such as maximum exercise capacity, measurements of blood flow, blood pressure, muscle metabolism, and muscle fatigue using advanced imaging techniques like Nuclear Magnetic Resonance (NMR). Researchers will monitor changes in limb blood flow and other outcomes at baseline and one hour after treatments. The study aims to provide detailed insight into how vascular function changes with age and disease and how it responds to various interventions over time.
CONDITIONS
Brief Title
: Vascular Function in Health and Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy young volunteers aged 18 to 30 years with no diseases or conditions affecting participation
- Healthy older volunteers aged 65 years or older with no diseases or conditions affecting participation
- Patients undergoing routine coronary angiography
- Patients diagnosed with mild to moderate chronic obstructive pulmonary disease (COPD)
- Patients with idiopathic or heritable Group 1 pulmonary arterial hypertension
- Patients with Class I, II, or III New York Heart Association symptoms of heart failure
- Patients diagnosed with chronic high blood pressure (hypertension)
You will not qualify if you...
- Severe COPD requiring supplemental oxygen or with a forced expiratory volume less than 30% predicted
- History of myocardial infarction
- History of percutaneous coronary revascularization
- History of coronary artery bypass grafting
- Unstable angina pectoris
- History of variant angina
- Ejection fraction less than 50%
- Significant renal disease with glomerular filtration rate less than 50 mL/min/1.73m2
- Medical conditions or devices that risk safety during MRI (e.g., pacemaker, metal implants, certain heart valves)
- Pregnancy
- Physical ailments other than COPD, pulmonary arterial hypertension, heart failure, or hypertension that prevent study participation according to investigator judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single day per assessment
Participants undergo catheter placement in femoral artery and vein, resting measurements of blood pressure, heart rate and blood flow, flow mediated vasodilation tests, muscle sympathetic nerve activity measurement, exercise tests, and NMR scanning to assess vascular function and metabolism before receiving various pharmacologic and antioxidant treatments.
Multiple visits depending on treatment assignments
Duration - Duration varies per participant
Participants engage in exercise training regimens designed to improve vascular function, muscle strength, and overall cardiovascular health, evaluated through repeated exercise bouts and physiological measurements.
Repeated exercise sessions over the study period
Duration - Single day per assessment
Participants repeat measurements including catheter-based assessments, exercise tests, and NMR scanning to evaluate changes in vascular function and metabolism following treatments and exercise training.
Multiple visits depending on treatment assignments
Trial Site Locations
Total: 1 location
1
George E Wahlen VA Medical Center
Salt Lake City, Utah, United States, 84132
Actively Recruiting
Research Team
M
Maydeen Ogara
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
7
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here